Personal Injury Law

Daytrana Patch Recall

Noven Pharmaceuticals Inc. said its partner Shire Ltd. is voluntarily recalling two lots of the attention deficit hyperactivity disorder drug patch Daytrana because of a problem with the patch liner.

In the recalled lots, the liner that needs to be released before the patch can be applied does not meet specifications, meaning patients might have difficulty removing the liner in order to apply the drug.

"Shire has advised that, because the voluntary recall is not due to product safety issues, all Daytrana patches, including those in the lots subject to the recall, can continue to be used unless the release liner cannot be removed, or the patches are damaged while being opened," Noven said, in a statement.

Link here.

Full post as published by A Georgia Lawyer on August 26, 2008 (boomark / email).